Inverness Medical Innovations is a publicly traded company trading on XNYS, led by CEO Kristin Yarema, with a market cap of $53.1M.
Common questions about Inverness Medical Innovations
Inverness Medical Innovations is scheduled to report earnings for Q1 2026 on May 15, 2026.
We use cookies for analytics. See our Privacy and Cookie Policy.